Language Interaction Network for Clinical Trial Approval Estimation
Clinical trial outcome prediction seeks to estimate the likelihood that a clinical trial will successfully reach its intended endpoint. This process predominantly involves the development of machine learning models that utilize a variety of data sources such as descriptions of the clinical trials, characteristics of the drug molecules, and specific disease conditions being targeted. Accurate predictions of trial outcomes are crucial for optimizing trial planning and prioritizing investments in a drug portfolio. While previous research has largely concentrated on small-molecule drugs, there is a growing need to focus on biologics-a rapidly expanding category of therapeutic agents that often lack the well-defined molecular properties associated with traditional drugs. Additionally, applying conventional methods like graph neural networks to biologics data proves challenging due to their complex nature. To address these challenges, we introduce the Language Interaction Network (LINT), a novel approach that predicts trial outcomes using only the free-text descriptions of the trials. We have rigorously tested the effectiveness of LINT across three phases of clinical trials, where it achieved ROC-AUC scores of 0.770, 0.740, and 0.748 for phases I, II, and III, respectively, specifically concerning trials involving biologic interventions.
Code (0)
등록된 구현이 없습니다.
Methods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
CTP-LLM: Clinical Trial Phase Transition Prediction Using Large Language Models
New medical treatment development requires multiple phases of clinical trials. Despite the significant human and financial costs of bringing a drug to market, less than 20% of drugs in testing will make it from the first…
Language ModellingLarge Language ModelAutomatically Labeling $200B Life-Saving Datasets: A Large Clinical Trial Outcome Benchmark
Background: The global cost of drug discovery and development exceeds $200 billion annually, with clinical trial outcomes playing a critical role in the regulatory approval of new drugs and impacting patient outcomes. De…
Drug DiscoveryLarge Language ModelSentiment AnalysisPyTrial: Machine Learning Software and Benchmark for Clinical Trial Applications
Clinical trials are conducted to test the effectiveness and safety of potential drugs in humans for regulatory approval. Machine learning (ML) has recently emerged as a new tool to assist in clinical trials. Despite this…
Synthetic Data GenerationTrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets
Clinical trials are pivotal for developing new medical treatments, yet they typically pose some risks such as patient mortality, adverse events, and enrollment failure that waste immense efforts spanning over a decade. A…
Simulating the Evolution of Signaling Signatures during CART-Cell -- Tumor Cell Interactions
Immunotherapies have been proven to have significant therapeutic efficacy in the treatment of cancer. The last decade has seen adoptive cell therapies, such as chimeric antigen receptor T-cell (CART-cell) therapy, gain F…